Therapeutic drug monitoring: linezolid too?
Author:
Publisher
Springer Science and Business Media LLC
Subject
Critical Care and Intensive Care Medicine
Link
http://link.springer.com/content/pdf/10.1186/s13054-014-0525-x.pdf
Reference9 articles.
1. Zoller M, Maier B, Hornuss C, Neugebauer C, Döbbeler G, Nagel D, Holdt L-M, Bruegel M, Weig T, Grabein B, Frey L, Teupser D, Vogeser M, Zander J: Variability of linezolid concentrations after standard dosing in critically ill patients: a prospective observational study. Crit Care. 2014, 18: R148-10.1186/cc13984.
2. Claus BO, Hoste EA, Colpaert K, Robays H, Decruyenaere J, De Waele JJ: Augmented renal clearance is a common finding with worse clinical outcome in critically ill patients receiving antimicrobial therapy. J Crit Care. 2013, 28: 695-700. 10.1016/j.jcrc.2013.03.003.
3. Lovering AM, Le Floch R, Hovsepian L, Stephanazzi J, Bret P, Birraux G, Vinsonneau C: Pharmacokinetic evaluation of linezolid in patients with major thermal injuries. J Antimicrob Chemother. 2009, 63: 553-559. 10.1093/jac/dkn541.
4. Wong G, Briscoe S, Adnan S, McWhinney B, Ungerer J, Lipman J, Roberts JA: Protein binding of β-lactam antibiotics in critically ill patients: can we successfully predict unbound concentrations?. Antimicrob Agents Chemother. 2013, 57: 6165-10.1128/AAC.00951-13.
5. Roberts JA, Paul SK, Akova M, Bassetti M, De Waele JJ, Dimopoulos G, Kaukonen KM, Koulenti D, Martin C, Montravers P, Rello J, Rhodes A, Starr T, Wallis SC, Lipman J: DALI: defining antibiotic levels in intensive care unit patients: are current β-lactam antibiotic doses sufficient for critically ill patients?. Clin Infect Dis. 2014, 58: 1072-1083. 10.1093/cid/ciu027.
Cited by 25 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Impact of a newly established expert clinical pharmacological advice programme based on therapeutic drug monitoring results in tailoring antimicrobial therapy hospital-wide in a tertiary university hospital: Findings after the first year of implementation;International Journal of Antimicrobial Agents;2023-08
2. Individualized antibiotic dosage regimens for patients with augmented renal clearance;Frontiers in Pharmacology;2023-07-26
3. A 600 mg of fixed‐dose linezolid in renally impaired patients versus 15 mg/kg intermittent dose‐optimized vancomycin in renally non‐impaired patients: A single centre retrospective analysis for adult patients with hospital‐acquired pneumonia due to methicillin‐resistant Staphylococcus aureus;Tropical Medicine & International Health;2023-03-23
4. Applicability of vancomycin, meropenem, and linezolid in capillary microsamples vs. dried blood spots: A pilot study for microsampling in critically ill children;Frontiers in Pediatrics;2023-01-10
5. Safety of linezolid in patients with decreased renal function and trough monitoring: a systematic review and meta-analysis;BMC Pharmacology and Toxicology;2022-11-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3